Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total published articles |
105 | 141 | 28 | 8 | 28 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
543 | 553 | 590 | 563 | 587 |
Journal total citations count | 6601 |
Journal impact factor | 6.49 |
Journal 5 years impact factor | 12.17 |
Journal cite score | 11.19 |
Journal h-index | 41 |
Journal h-index since 2019 | 26 |
Gerlinger, Gabriel, Marta Hauser, Marc De Hert, Kathleen Lacluyse, Martien Wampers, and Christoph U. Correll. "Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions." World Psychiatry 12, no. 2 (2013): 155-164. |
|
Cabrera-Abreu, Casimiro. "It is now personal: recent views on the assessment of therapeutic infidelity in severe mental illness." Current clinical pharmacology 6, no. 2 (2011): 78-82. |
|
Semble, Holly E., and Michele J. Dadson. "Adherence to antipsychotic therapy: Risk and protective factors." Child and Adolescent Psychopharmacology News 16, no. 2 (2011): 1-4. |
|
Meyer, Marie-Astrid, Sébastien Colson, Aurélia Rolland, Raphaël Gaillard, Jean-Yves Masquelier, and Marion Plaze. "Efficience d’une consultation psychiatrique pour les patients souffrant de schizophrénie résistante: vers une coordination par une infirmière en pratique avancée en France." Revue Francophone Internationale de Recherche Infirmière (2021). |
|
Esra, U. S. L. U., and Kadriye BULDUKO?LU. "?izofrenide ilaç tedavisine uyum ve psikiyatri hem?iresinin rolü." Ankara Sa?l?k Bilimleri Dergisi 7, no. 1 (2018): 61-72. |
|
Urban, Anna Emilia, Maria Ga?uszko-W?gielnik, and Wies?aw Jerzy Cuba?a. "Przegl?d interwencji w polekowym przyro?cie masy cia?a podczas leczenia klozapin?." Psychiatria i Psychologia Kliniczna 2, no. 15 (2015): 76-80. |
|
Bareis, Natalie, Juan Lu, Cynthia K. Kirkwood, Susan G. Kornstein, Elwin Wu, and Briana Mezuk. "Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)." Journal of affective disorders 238 (2018): 147-155. |
|
MacDonald, Lindsay Allison. "Medication adherence in bipolar disorder: Understanding patients’ perspectives to inform intervention development." PhD diss., UCL (University College London), 2017. |
|
De las Cuevas, Carlos, Lilisbeth Perestelo, Amado Rivero, Jeanette Pérez, Marien González, and Alia Pérez-Wehbe. "Attitudes towards prescribing psychiatric medicines: do the views of psychology and medical students differ?." Open Journal of Psychiatry 1, no. 03 (2011): 115. |
|
De las Cuevas, Carlos, and Wenceslao Peñate. "Propiedades psicométricas de la Escala Morisky de Adherencia a los Medicamentos (MMAS-8-ítems) en pacientes psiquiátricos ambulatorios." International Journal of Clinical and Health Psychology 15, no. 2 (2015): 121-129. |
|
Howes, Oliver D., Francis Vergunst, Siobhan Gee, Philip McGuire, Shitij Kapur, and David Taylor. "Adherence to treatment guidelines in clinical practice: study of." |
|
Uslu, Esra, and Kadriye Buldukoglu. "Randomized controlled trial of the effects of nursing care based on a telephone intervention for medication adherence in schizophrenia." Perspectives in psychiatric care 56, no. 1 (2019): 63-71. |
|
Riesenberg, Robert, Joshua Rosenthal, Leslie Moldauer, and Christine Peterson. "Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder." Psychopharmacology 221, no. 4 (2012): 601-610. |
|
Vanes, Lucy Denise. "A Systems Neuroscience Perspective on Treatment Resistant Schizophrenia: The Role of Cognitive Control, Reinforcement Learning, and Myelination." PhD diss., King's College London, 2018. |
|
Jiménez Herrera, Luis. "Adherencia terapéutica y oportunidades de mejora del estado salud-enfermedad." Revista Costarricense de Salud Pública 23, no. 1 (2014): 68-74. |
|
Lin, Ching-Hua, Hung-Yu Chan, Chun-Chi Hsu, and Feng-Chua Chen. "Temporal trends in clozapine use at time of discharge among people with schizophrenia at two public psychiatric hospitals in Taiwan, 2006–2017." Scientific reports 10, no. 1 (2020): 1-8. |
|
Leclerc, Louis-David, Marie-France Demers, Andrea Bardell, Isabelle Bilodeau, Richard Williams, Phil Tibbo, and Marc-André Roy. "A Chart Audit Study of Clozapine Utilization in Early Psychosis." Journal of Clinical Psychopharmacology 41, no. 3 (2021): 275-280. |
|
Staton, Dennis. "Achieving adolescent adherence to treatment of major depression." Adolescent health, medicine and therapeutics 1 (2010): 73. |
|
Frey, Simon, and Tom Stargardt. "Performance of compliance and persistence measures in predicting clinical and economic outcomes using administrative data from German sickness funds." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32, no. 10 (2012): 880-889. |
|
Lally, John, and James H. MacCabe. "Epidemiology, impact, and predictors of treatment-resistant schizophrenia." Treatment Response and Resistance in Schizophrenia (2018): 35. |
|